Article
Chemerin is associated with inflammatory markers and metabolic syndrome phenotypes in hypertension patients.
Clinical and experimental hypertension (New York, N.Y. : 1993) - 1 Jan 2014
Gu Ping, Jiang Weimin, Lu Bin, Shi Zhaorong
Abstract excerpt
BACKGROUND: Chemerin is a new adipokine elevated in states of obesity and metabolic syndrome. In order to identify the role of chemerin in hypertension, we conducted a case--control study to evaluate the role of chemerin in hypertension. METHODS: Two hundred and thirty-seven new-diagnosed essential hypertensive (EH) patients and one hundred and ten normotensive healthy subjects (NT) were enrolled. After an...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
